Increasing the safety and efficacy of chimeric antigen receptor T cell therapy
Abstract Chimeric antigen receptor (CAR) T cell therapy is a promising cancer treatment that has recently been undergoing rapid development. However, there are still some major challenges, including precise tumor targeting to avoid off-target or “on-target/off-tumor” toxicity, adequate T cell infilt...
Main Authors: | Hua Li, Yangbing Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2017-04-01
|
Series: | Protein & Cell |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1007/s13238-017-0411-9 |
Similar Items
-
Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9
by: Jiangtao Ren, et al.
Published: (2017-04-01) -
Building Potent Chimeric Antigen Receptor T Cells With CRISPR Genome Editing
by: Jie Liu, et al.
Published: (2019-03-01) -
Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy
by: Stefan Stoiber, et al.
Published: (2019-05-01) -
Chimeric antigen receptor T-cell therapy in hematopoietic and nonhematopoietic malignancies
by: Faizan Ahmad
Published: (2020-01-01) -
Construction and Functional Characterization of a Fully Human Anti-mesothelin Chimeric Antigen Receptor (CAR) Expressing T Cell
by: Leila Jafarzadeh, et al.
Published: (2020-06-01)